Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

University of Perugia

Headquarters: Perugia, Italy
Year Founded: 1308
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | May 13, 2022
Data Byte

Distillery spotlight on Italian innovation

Opportunities include compounds and targets for cancer, neurology and musculoskeletal diseases, and discoveries from company founders
BioCentury | Aug 27, 2021
Distillery Therapeutics

A tryptophan catabolite to treat psoriasis and nephritis

BioCentury | Apr 13, 2017
Targets & Mechanisms

Cool and also collected

Thymosin α1 may be a rare one-stop shop for cystic fibrosis
BioCentury | Apr 11, 2017
Distillery Therapeutics

Pulmonary; infectious disease

BioCentury | Mar 24, 2016
Distillery Therapeutics

Therapeutics: Interleukin-1 receptor

BioCentury | Jul 24, 2014
Distillery Therapeutics

Indication: Infectious disease

BioCentury | Mar 31, 2014
Emerging Company Profile

ImmuSmol: Going small

ImmuSmol's antibodies target metabolites involved in tumor immune evasion
BioCentury | Mar 18, 2013
Emerging Company Profile

gIcare: Colonoscopy comfort

gIcare developing non-sedating, lower cost analgesics for colonoscopy
BioCentury | Apr 19, 2012
Distillery Therapeutics

Indication: Infectious disease

Items per page:
1 - 10 of 22